Concepedia

Elizabeth Larocque

EL

7

Publications

133

Citations

7

H-Index

2017

Active since

Affiliations

Purdue University West Lafayette(Current)

University of Maryland, College Park

Center for Cancer Research

University of Maryland, Baltimore

U-M Rogel Cancer Center

Elizabeth Larocque is an author at Purdue University West Lafayette specializing in drug development, drug discovery, and medicine.

Top concepts

MedicinePharmacologyDrug DiscoveryDrug DevelopmentCell BiologyTumor BiologyPharmacotherapyMedicinal ChemistryBiochemistryMolecular Pharmacology

Publications per year

2017–2023

7

Publications

7

Use of High-Throughput Tools for Telescoped Continuous Flow Synthesis of an Alkynylnaphthyridine Anticancer Agent, HSN608

Shruti A. Biyani, Qingqing Qi, Jingze Wu et al. · Organic Process Research & Development · 2020 · 31 citations

Lead Compounds, Combinatorial Chemistry, Medicinal Chemistry +15

Identification of New FLT3 Inhibitors That Potently Inhibit AML Cell Lines via an Azo Click-It/Staple-It Approach

Xiaochu Ma, Jie Zhou, Changhao Wang et al. · ACS Medicinal Chemistry Letters · 2017 · 22 citations · Full text

Aml Patients, Pharmacotherapy, Tumor Biology +18

Amino alkynylisoquinoline and alkynylnaphthyridine compounds potently inhibit acute myeloid leukemia proliferation in mice

Nimishetti Naganna, Clement Opoku‐Temeng, Eun Yong Choi et al. · EBioMedicine · 2019 · 19 citations · Full text

Nicotinamide–Ponatinib Analogues as Potent Anti-CML and Anti-AML Compounds

Elizabeth Larocque, Elizabeth Fei Yin Chu, Herman O. Sintim · ACS Omega · 2020 · 18 citations · Full text

Pharmacotherapy, Pharmaceutical Chemistry, Nicotinamide Analogs +17

Aminoisoquinoline Benzamides, Flt3 and Src-Family Kinase Inhibitors, Potently Inhibit Proliferation of Acute Myeloid Leukemia Cell Lines

Elizabeth Larocque, Nimishetti Naganna, Xiaochu Ma et al. · Future Medicinal Chemistry · 2017 · 16 citations · Full text

Rows per page

1–5 of 7